Measures of Brain Metabolism and Diffusion in Neonates of Mothers with Diabetes

Steve C N Hui1,2,3, Nahla M H Elsaid1,2,3, Julius S Ngwa1,3

  • 1From the Developing Brain Institute (S.C.N.H., N.M.H.E., J.S.N., K.K., C.L., N.A.), Children's National Hospital, Washington, DC.

Insights

Infants of diabetic mothers (IDMs) show altered brain metabolites, specifically increased myo-inositol. Diffusion MRI reveals changes in white matter integrity, suggesting potential neurodevelopmental impacts in IDMs.

Area of Science:

  • Neonatal neurodevelopment
  • Pediatric neuroimaging
  • Metabolic disorders

Background:

  • Maternal diabetes mellitus (DM) can impact offspring neurodevelopment.
  • Early detection of brain abnormalities in infants of diabetic mothers (IDMs) is crucial.
  • Brain metabolites and white matter tracts are key indicators of neonatal brain health.

Purpose of the Study:

  • To compare brain metabolites and white matter fiber structures in IDMs versus healthy controls.
  • To investigate early neurodevelopmental changes in infants exposed to maternal diabetes.
  • To identify potential biomarkers for brain abnormality in neonates of diabetic mothers.

Main Methods:

  • Prospective recruitment of pregnant women with DM and healthy controls.
  • Acquisition of 3T MRI data, including T2-weighted images, 1H-MRS, and diffusion tensor imaging (DTI).
  • Comparison of brain metabolites (e.g., myo-inositol, GABA) and diffusion measures (MD, AD) between IDMs and controls using independent sample t-tests and general linear models.

Main Results:

  • MRI data obtained from 77 newborns (41 controls, 36 IDMs).
  • Significantly higher myo-inositol levels in IDMs compared to controls (p=0.02).
  • Increased mean diffusivity (MD) and axial diffusivity (AD) in specific regions of the cingulate gyrus in IDMs, indicating altered white matter integrity.

Conclusions:

  • Elevated myo-inositol in IDMs may represent a compensatory response to altered maternal blood glucose levels.
  • Increased diffusivity in IDMs suggests potential abnormalities in myelination and axonal development.
  • These findings highlight subtle but significant neuroimaging differences in IDMs, warranting further investigation into long-term neurodevelopmental outcomes.
Abstract